113 related articles for article (PubMed ID: 15723402)
1. Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease.
Li X; Huang W; Yankeelov TE; Tudorica A; Rooney WD; Springer CS
Magn Reson Med; 2005 Mar; 53(3):724-9. PubMed ID: 15723402
[TBL] [Abstract][Full Text] [Related]
2. Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.
Yankeelov TE; Rooney WD; Huang W; Dyke JP; Li X; Tudorica A; Lee JH; Koutcher JA; Springer CS
NMR Biomed; 2005 May; 18(3):173-85. PubMed ID: 15578708
[TBL] [Abstract][Full Text] [Related]
3. Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape.
Yankeelov TE; Rooney WD; Li X; Springer CS
Magn Reson Med; 2003 Dec; 50(6):1151-69. PubMed ID: 14648563
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
Huang W; Tudorica LA; Li X; Thakur SB; Chen Y; Morris EA; Tagge IJ; Korenblit ME; Rooney WD; Koutcher JA; Springer CS
Radiology; 2011 Nov; 261(2):394-403. PubMed ID: 21828189
[TBL] [Abstract][Full Text] [Related]
5. Shutter-speed dynamic contrast-enhanced MRI: Is it fit for purpose?
Buckley DL
Magn Reson Med; 2019 Feb; 81(2):976-988. PubMed ID: 30230007
[TBL] [Abstract][Full Text] [Related]
6. The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.
Huang W; Li X; Morris EA; Tudorica LA; Seshan VE; Rooney WD; Tagge I; Wang Y; Xu J; Springer CS
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17943-8. PubMed ID: 19004780
[TBL] [Abstract][Full Text] [Related]
7. First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia.
Li X; Springer CS; Jerosch-Herold M
NMR Biomed; 2009 Feb; 22(2):148-57. PubMed ID: 18727151
[TBL] [Abstract][Full Text] [Related]
8. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
Kim S; Quon H; Loevner LA; Rosen MA; Dougherty L; Kilger AM; Glickson JD; Poptani H
J Magn Reson Imaging; 2007 Dec; 26(6):1607-17. PubMed ID: 17968962
[TBL] [Abstract][Full Text] [Related]
9. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
10. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
11. A modified logistic model to describe gadolinium kinetics in breast tumors.
Moate PJ; Dougherty L; Schnall MD; Landis RJ; Boston RC
Magn Reson Imaging; 2004 May; 22(4):467-73. PubMed ID: 15120165
[TBL] [Abstract][Full Text] [Related]
12. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
[TBL] [Abstract][Full Text] [Related]
13. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
14. Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle.
Buckley DL; Kershaw LE; Stanisz GJ
Magn Reson Med; 2008 Nov; 60(5):1011-9. PubMed ID: 18956419
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.
Autenshlyus AI; Arkhipov SA; Kunts TA; Marinkin IO; Mikhailova ES; Karpukhina XV; Varaksin NA
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):83-88. PubMed ID: 27903846
[TBL] [Abstract][Full Text] [Related]
17. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
18. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
19. Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors.
Franzén B; Auer G; Alaiya AA; Eriksson E; Uryu K; Hirano T; Okuzawa K; Kato H; Linder S
Int J Cancer; 1996 Oct; 69(5):408-14. PubMed ID: 8900376
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
